Gå direkt till huvudinnehållet

Snusanvändning

Senast reviderad:
Sakkunnig:

  1. Nationella folkhälsoenkäten – Hälsa på lika villkor. Folkhälsomyndigheten 2021. www.folkhalsomyndigheten.se  
  2. Roosaar A, Johansson ALV, Sandborgh-Englund G, Nyrén O, Axéll T. A long-term follow-up study on the natural course of snus-induced lesions among Swedish snus users. Int J Cancer 2006; 119: 392-7. PubMed  
  3. Luo J, Ye W, Zendehdel K, et al. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 2007; 369: 2015-20. PubMed  
  4. Wilson KM, Markt SC, Fang F, Nordenvall C, Rider JR, Ye W, Adami HO, Stattin P, Nyrén O, Mucci LA. Snus use, smoking and survival among prostate cancer patients. Int J Cancer. 2016 Dec 15;139(12):2753-2759. doi: 10.1002/ijc.30411. PMID: 27582277 PubMed  
  5. Araghi M, Galanti MR, Lundberg M, Liu Z, Ye W, Lager A, Engström G, Manjer J, Alfredsson L, Knutsson A, Norberg M, Palmqvist R, Gylling B, Wennberg P, Lagerros YT, Bellocco R, Pedersen NL, Östergren PO, Magnusson C. Smokeless tobacco (snus) use and colorectal cancer incidence and survival: Results from nine pooled cohorts. Scand J Public Health. 2017 Dec;45(8):741-748. doi: 10.1177/1403494817714191. Epub 2017 Oct 10. PMID: 28994648 PubMed  
  6. Carlsson S, Andersson T1, Araghi M, et al. Smokeless tobacco (snus) is associated with an increased risk of type 2 diabetes: results from fivepooled cohorts. J Intern Med. 2017 Feb 6. PMID: 28164394. PubMed  
  7. Vidyasagaran AL, Siddiqi K, Kanaan M. Use of smokeless tobacco and risk of cardiovascular disease: A systematic review and meta-analysis. Eur J Prev Cardiol. 2016 Dec;23(18):1970-1981. doi: 10.1177/2047487316654026. Epub 2016 Jul 10. PMID: 27256827 PubMed  
  8. Wikström AK, Cnattingius S, Galanti MR, et al. Effect of Swedish snuff (snus) on preterm birth. BJOG 2010; 117: 1005-10. PubMed  
  9. Wikström AK, Cnattingius S, Stephansson O. Maternal use of Sweedish snuff (snus) and risk of stillbirth. Epidemiology 2010; 21: 772-8. PubMed  
  10. Gunnerbeck A, Wikström AK, Bonamy AKE, et al. Relationship of maternal snuff use and cigarette smoking with neonatal apnea. Pediatrics 2011; 128: 503-9. PMID: 21873701 PubMed  
  11. Gunnerbeck A, Edstedt Bonamy A-K, Wikström A-K, et al. Maternal snuff use and smoking and the risk of oral cleft malformations - a population-based cohort. PlosOne 2014; 9: e84715. doi:10.1371/journal.pone.0084715. PMID: 24454740 PubMed  
  12. Løchen ML, Henrichsen SH, Grimsrud TK, Holmen TL, Gallefoss F. Use of snus during pregnancy is not without risk. Tidsskr Nor Laegeforen. 2012 Apr 30;132(8):932-3. English, Norwegian. doi: 10.4045/tidsskr.12.0216. PMID: 22562321. PubMed  
  13. Coleman T, Chamberlain C, Cooper S, Leonardi-Bee J. Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and meta-analysis. Addiction 2011; 106: 52-61. pmid:PMID: 21054620 PubMed  
  14. Hatsukami DK, Keenan RM, Anton DJ. Topographical features of smokeless tobacco use. Psychopharmacology (Berl). 1988;96(3):428-9. doi: 10.1007/BF00216076. PMID: 3146780 PubMed  
  15. Post A, Gilljam H, Rosendal I, Bremberg S, Galanti MR. Symptoms of nicotine dependence in a cohort of sweedish youths: a comparison between smokers, smokeless tobacco users and dual tobacco users. Addiction 2010; 105: 740-6. PubMed  
  16. Nationellt vårdprogram vid ohälsosamma levnadsvanor – prevention och behandling. Nationellt programområde för levnadsvanor (hämtad 2022-02-02) nationelltklinisktkunskapsstod.se  
  17. Nationella riktlinjer för prevention och behandling vid ohälsosamma levnadsvanor. Socialstyrelsen 2018. www.socialstyrelsen.se  
  18. Ebbert JO, Elrashidi MY, Stead LF. Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev. 2015 Oct 26;2015(10):CD004306. doi: 10.1002/14651858.CD004306.pub5. PMID: 26501380 PubMed  
  19. Ebbert JO, Fagerström K. Pharmacological interventions for the treatment of smokeless tobacco use. CNS Drugs 2012; 26: 1-10. pmid:22136150 PubMed  
  20. Dale LC, Ebbert JO, Glover ED, et al. Bupropion SR for the treatment of smokeless tobacco use. Drug Alcohol Depend 2007; 90: 56-63. pmid:17353101 PubMed  
  21. Hajat C, Stein E, Ramstrom L, Shantikumar S, Polosa R. The health impact of smokeless tobacco products: a systematic review. Harm Reduct J. 2021 Dec 4;18(1):123. doi: 10.1186/s12954-021-00557-6. PMID: 34863207 PubMed  
  • Anna Nager, docent och specialist i allmänmedicin, Karolinska institutet